Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular Carcinoma

Abstract

To investigate the difference in expression of hTERT, gene between HbsAg-positive human hepatocellular carcinoma (HCC) and HbsAg-negative HCC and to explore the relationship between HBV infection and hTERT gene expression in HCC. The expression of hTERT protein in 30 cases of HbsAg positive HCC and 17 cases of HbsAg negative HCC was detected by immunohistochemistry (SP method), and the expression of hTERT mRNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR).t-test, Chi-squared test and cochrans-armitage trend test were used to see whether there was an interrelation between HBsAg and hTERT gene in HCC. The expression of hTERT protein was mostly located in plasm and occasionally in the nucleus of liver cancer cells. The positive rate of hTERT protein and hTERT mRNA in HbsAg positives HCC-93.33% (28/30) and 83.33% (25/30) respectively which were much higher than those in HbsAg negative HCC-52.94% (9/17), 47.06% (8/17) (P<0.01) respectively. HbsAg is related to hTERT gene expression in human hepatocellular carcinoma. The hTERT gene activated by the efficacious ingredient of HBV may play an important role in hepatocellular transformation and carcinogenesis.

Keywords

HbsAg / Carcinoma, hepatocellular / hTERT / Gene expression

References

[1] TaharaH, NakanishT, KitamotoM, et al.. Telomerase activity inhuman liver tissues: comparison between chronic liver diseaseand hepatocellular carcinoma. Cancer Res, 1995, 55: 2734-2734

[2] Paterlini-brechotPatrizia, Saigokenichi, MurakamiYoshiki, et al.. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene, 2003, 22: 3911-3911

[3] LeemSun-Hee, Londono-VallejoJ Arturo, Jung-Hyun, et al.. The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene, 2002, 21: 769-769

[4] OnoY, OndaH, SasadaR, et al.. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res, 1983, 11: 1747-1747

[5] FerberM J, MontoyaD P, YuC, et al.. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene, 2003, 22: 3813-3813

[6] HsiehH F, HarnH J, ChiuS C, et al.. Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma. Liver, 2000, 20: 143-143

[7] ChungTae-Wook, LeeYoung-Choon, KoJeong-Heon, et al.. Hepatitis B virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activitor in liver cells. Cancer Research, 2003, 63: 3453-3453

[8] OgamiMasayuki, IkuraYoshihiro, NishiguchiShuhei, et al.. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Laboratory Investigations, 1999, 79: 19-19